Free Trial

Bone Biologics (BBLG) Earnings Date, Estimates & Call Transcripts

Bone Biologics logo
$2.20 +0.03 (+1.38%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$2.20 +0.00 (+0.23%)
As of 08/22/2025 06:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bone Biologics Earnings Summary

Bone Biologics issued Q2 2025 earnings on August 14, 2025, reporting an EPS of -$1.33, which missed the consensus estimate of -$0.58 by $0.75. With a trailing EPS of $0.00, Bone Biologics' earnings are expected to grow next year, from ($5.00) to ($1.95) per share.

Q2 2025 Earnings Resources

Latest Q2 2025
Earnings Date
Aug. 14Estimated
Consensus EPS
(Aug. 14)
-$0.58
Actual EPS
(Aug. 14)
-$1.33 Missed By -$0.75
Get Bone Biologics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bone Biologics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BBLG Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Bone Biologics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$3.24-$3.24-$3.24
Q2 20251-$1.93-$1.93-$1.93
Q3 20251-$1.79-$1.79-$1.79
Q4 20251-$1.66-$1.66-$1.66

Bone Biologics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025-$0.58-$1.33 -$0.75-$1.33--
5/12/2025Q1 2025-$2.88-$1.92+$0.96-$0.32--
8/9/2024--$8.34-$4.02+$4.32-$0.67--
5/14/2024Q1 2024-$45.60-$7.86+$37.74-$1.31--
11/14/2023Q3 2023-$145.92-$29.28+$116.64-$0.61--

Bone Biologics Earnings - Frequently Asked Questions

Bone Biologics (NASDAQ:BBLG) last announced its quarterly earning data on Thursday, August 14, 2025. Learn more on BBLG's earnings history.

In the previous quarter, Bone Biologics (NASDAQ:BBLG) missed the analysts' consensus estimate of ($0.58) by $0.75 with a reported earnings per share (EPS) of ($1.33). Learn more on analysts' earnings estimate vs. BBLG's actual earnings.

Bone Biologics (NASDAQ:BBLG) has a recorded net income of -$4.11 million. BBLG has generated $0.00 earnings per share over the last four quarters.

Bone Biologics' earnings are expected to grow from ($5.00) per share to ($1.95) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:BBLG) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners